Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Susan G. Komen Breast Cancer Foundation
Daiichi-Sankyo Pharma Development
Triple Negative Breast Cancer Foundation
Information provided by (Responsible Party):
Andres Forero, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT01307891
First received: March 1, 2011
Last updated: June 18, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2015
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)